Valuation: Sera Prognostics, Inc.

Market Cap 80.08M 71.48M 66.44M 60.43M 114M 7.58B 116M 798M 312M 3.96B 301M 294M 12.66B P/E 2026 *
-3.09x
P/E 2027 * -3.79x
Enterprise Value 80.08M 71.48M 66.44M 60.43M 114M 7.58B 116M 798M 312M 3.96B 301M 294M 12.66B EV / Sales 2026 *
356x
EV / Sales 2027 * 41.6x
Free-Float
85.71%
Yield 2026 *
-
Yield 2027 * -
1 day-1.93%
1 week+0.50%
Current month-2.87%
1 month+2.01%
3 months-6.02%
6 months-6.88%
Current year-31.19%
1 week 2.03
Extreme 2.03
2.1
1 month 2
Extreme 2
2.21
Current year 1.56
Extreme 1.56
3.85
1 year 1.56
Extreme 1.56
3.95
3 years 1.37
Extreme 1.37
12.36
5 years 1.1
Extreme 1.1
12.36
10 years 1.1
Extreme 1.1
15.5
Manager TitleAgeSince
Chief Executive Officer 52 2023-05-31
Director of Finance/CFO 47 2026-08-30
Chief Tech/Sci/R&D Officer - 2021-12-31
Director TitleAgeSince
Chairman 74 2011-04-19
Chairman 58 2023-06-07
Director/Board Member 59 2011-10-31
Date Insider Type Main position Quantity % Market Cap. Importance
10/12/26 Sell

Chief Technology Officer

-8,024 0.0209%
9/10/26 Sell

Chief Executive Officer

-7,022 0.0182%
9/10/26 Sell

General Counsel

-2,190 0.0057%
Change 5-day change 1-year change 3-year change Capi.($)
-1.93%+0.50%-35.14%+6.28% 81.66M
+2.13%+6.57%+15.64%+68.20% 719B
+2.12%+5.94%+13.66%+66.25% 82.84B
+1.23%-0.24%+2.70%+141.91% 64.41B
+1.29%-14.25%+49.73%+894.77% 50.99B
+1.89%+3.89%-15.92%+2.53% 47.99B
+5.25%+6.11%+4.86%+84.92% 45.85B
+1.19%+2.22%+9.10%+26.09% 30.98B
+3.35%+1.02%+41.15%+62.86% 25.81B
+2.47%+2.76%-61.02%-58.03% 24.5B
Average +1.65%+0.72%+2.48%+129.58% 109.2B
Weighted average by Cap. +2.05%+4.33%+13.17%+104.65%

Financials

2026 *2027 *
Net sales 225K 201K 187K 170K 319K 21.31M 325K 2.24M 877K 11.12M 844K 826K 35.58M 1.92M 1.72M 1.6M 1.45M 2.73M 182M 2.78M 19.18M 7.51M 95.13M 7.22M 7.07M 304M
Net income -33.93M -30.29M -28.15M -25.61M -48.18M -3.21B -49.04M -338M -132M -1.68B -127M -125M -5.37B -29.1M -25.97M -24.14M -21.96M -41.31M -2.76B -42.06M -290M -113M -1.44B -109M -107M -4.6B
Net Debt - -
Projected Income Statement - Annual - Sera Prognostics, Inc.
Logo Sera Prognostics, Inc.
Sera Prognostics, Inc. is a women's health diagnostic company utilizing its proprietary proteomics and bioinformatics platform, and significant data resources to enhance maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. It has built a proteomics and bioinformatics platform to characterize the biology of pregnancy and to discover and validate key protein biomarkers found in blood that are accurate predictors of dynamic changes that occur during pregnancy. Its commercial product, the PreTRM test, is a validated, commercially available blood-based biomarker test to predict the risk of a premature delivery, also known as preterm birth. The PreTRM test is a non-invasive blood test given to a pregnant woman, carrying a single fetus, during weeks 18 through 20 of gestation that provides a prediction of the expectant mother’s risk of delivering spontaneously before 37 weeks’ gestation.
Employees
72
Date Price Change Volume
26-10-15 US$2.030 -1.93% 13,300
26-10-14 US$2.070 +1.47% 5,838
26-10-13 US$2.040 -1.45% 4,686
26-10-12 US$2.070 +1.47% 13,799
26-10-09 US$2.040 +0.99% 6,298
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Sera Prognostics, Inc.
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
2.030USD
Average target price
5.500USD
Spread / Average Target
+170.94%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Sera Prognostics, Inc.
  1. Stock Market
  2. Stocks
  3. SERA Stock